Abstract
Sickle Cell Disease (SCD) is the most frequent hereditary hemoglobinopathy in the world, which despite the advances in pathophysiological knowledge and in the treatment of support, continues to have a great negative impact on the quality of life and survival of patients. It has been known for at least 50 years that patients with SCD have elevated levels of free heme in circulation, associ…